Platinum‐Based TREM2 Inhibitor Suppresses Tumors by Remodeling the Immunosuppressive Microenvironment-Reference-Cited by-全球学者库

Platinum‐Based TREM2 Inhibitor Suppresses Tumors by Remodeling the Immunosuppressive Microenvironment

Published:2022-12-07 Issue:2 Volume:62 Page:
ISSN:1433-7851
Container-title:Angewandte Chemie International Edition
language:en
Short-container-title:Angew Chem Int Ed

Author:

Yang Tao¹²,Zhang Shuren¹²,Yuan Hao¹,Wang Ying³,Cai Linxiang³,Chen Hanhua³,Wang Xiaoyu¹,Song Dongfan¹,Wang Xiaohui⁴,Guo Zijian¹²,Wang Xiaoyong³^ORCID

Affiliation:

1. State Key Laboratory of Coordination Chemistry School of Chemistry and Chemical Engineering Nanjing University Nanjing 210023 P. R. China

2. Chemistry and Biomedicine Innovation Center Nanjing University Nanjing 210023 P. R. China

3. State Key Laboratory of Pharmaceutical Biotechnology School of Life Sciences Nanjing University Nanjing 210023 P. R. China

4. Institute of Chemical Biology and Functional Molecules, State Key Laboratory of Materials-Oriented Chemical Engineering, School of Chemistry and Molecular Engineering Nanjing Tech University Nanjing 211816 P. R. China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Jiangsu Province

China Postdoctoral Science Foundation

Publisher

Wiley

Subject

General Chemistry,Catalysis

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/anie.202213337

Reference79 articles.

2. Direct Cellular Responses to Platinum-Induced DNA Damage

3. Consensus guidelines for the detection of immunogenic cell death

4. Platinum Drug Distribution in Cancer Cells and Tumors

5. The future of cancer immunotherapy: microenvironment-targeting combinations

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient‐derived Immunocompetent Tumor Organoids: A Platform for Chemotherapy Evaluation in the Context of T‐cell Recognition**;Angewandte Chemie;2024-01-24

2. Patient‐derived Immunocompetent Tumor Organoids: A Platform for Chemotherapy Evaluation in the Context of T‐cell Recognition**;Angewandte Chemie International Edition;2024-01-24

3. Series of Desloratadine Platinum(IV) Hybrids Displaying Potent Antimetastatic Competence by Inhibiting Epithelial–Mesenchymal Transition and Arousing Immune Response;Journal of Medicinal Chemistry;2024-01-17

4. Antitumor Effect of Platinum-Modified STING Agonist MSA-2;ACS Omega;2024-01-03

5. Development of Platinum Complexes for Tumor Chemoimmunotherapy;Chemistry – A European Journal;2024-01-03